resveratrol has been researched along with charybdotoxin in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Argüelles, CF; Granados-Soto, V; Ortiz, MI | 1 |
| Djukanovic, B; Gojkovic-Bukarica, L; Heinle, H; Markovic-Lipkovski, J; Nezic, D; Novakovic, A; Peric, M | 1 |
| Bukarica, LG; Heinle, H; Kanjuh, V; Novakovic, A | 1 |
3 other study(ies) available for resveratrol and charybdotoxin
| Article | Year |
|---|---|
The peripheral antinociceptive effect of resveratrol is associated with activation of potassium channels.
Topics: 4-Aminopyridine; Animals; Anti-Inflammatory Agents, Non-Steroidal; Apamin; ATP-Binding Cassette Transporters; Charybdotoxin; Female; Glipizide; Glyburide; KATP Channels; Morphine; Narcotics; Peripheral Nervous System; Potassium Channel Blockers; Potassium Channels; Potassium Channels, Calcium-Activated; Potassium Channels, Inwardly Rectifying; Rats; Rats, Wistar; Resveratrol; Stilbenes; Tetraethylammonium; Tolbutamide | 2002 |
The mechanism of endothelium-independent relaxation induced by the wine polyphenol resveratrol in human internal mammary artery.
Topics: 4-Aminopyridine; Anti-Arrhythmia Agents; Charybdotoxin; Coronary Artery Bypass; Coronary Disease; Glyburide; Humans; Male; Mammary Arteries; Middle Aged; Muscle Relaxation; Muscle, Smooth, Vascular; Neurotoxins; Potassium Channel Blockers; Potassium Channels; Resveratrol; Scorpion Venoms; Stilbenes; Tetraethylammonium; Vasodilation; Vasodilator Agents; Wine | 2006 |
Potassium channels-mediated vasorelaxation of rat aorta induced by resveratrol.
Topics: 4-Aminopyridine; Animals; Antioxidants; Aorta; Charybdotoxin; Dose-Response Relationship, Drug; Drug Interactions; Endothelium, Vascular; Glyburide; In Vitro Techniques; Male; Potassium Channel Blockers; Potassium Channels; Rats; Rats, Wistar; Resveratrol; Scorpion Venoms; Stilbenes; Tetraethylammonium; Vasodilation; Vasodilator Agents | 2006 |